A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies
|
|||||
       |
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company 
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs. . . . → Read More: Company Gains Ultrasound-Linked Drug Capsule Technology 
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders. . . . → Read More: Companies to Assess Ovarian Health Biotech Drug  One comment - (Comments are closed)  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded Comments are closed Intellectual property agriculture, biotechnology, Canada, chemistry, engineering, life sciences, patent, physical sciences, USPTO 
A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques One comment - (Comments are closed) Intellectual property biomedical, biotechnology, chemistry, engineering, entrepreneurs, genomics, licensing, life sciences, materials science, patent, pharmaceuticals, physical sciences, university, USPTO 
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal 
Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, chemistry, engineering, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences 
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M One comment - (Comments are closed) Finance, Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease. . . . → Read More: Start-Up Licensing Antibody Eye Drops for Dry Eye Disease Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts